Results 91 to 100 of about 2,547,606 (153)

Biomedical Data Manifest: A lightweight data documentation mapping to increase transparency for AI/ML. [PDF]

Sci Data
Bottomly D, Suciu CG, Cordier B, Evans N, Poire A, Zheng C, ARTNet Consortium, Tyner JW, Hutson A, McWeeney SK.   +9 more
europepmc   +1 more source

Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer. [PDF]

Oncogene
Witkiewicz AK, Wang J, Schultz E, O'Connor TN, O'Connor T, Levine E, Knudsen ES.   +6 more
europepmc   +1 more source

S. I. Witkiewicz, artiste aux talents multiples, hier et aujourd'hui

, 2018
Wojda, Aleksandra, Fiszer, Stanislaw
openaire   +1 more source

Robot-Assisted Colorectal Cancer Surgery Mitigates Early Postoperative Immunosuppression and Angiogenesis. [PDF]

Int J Mol Sci
Fleszar MG, Zawadzki M, Fortuna P, Bednarz-Misa I, Krauze I, Maciejewska K, Klekowski J, Chabowski M, Witkiewicz W, Krzystek-Korpacka M.   +9 more
europepmc   +1 more source

Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222. [PDF]

Cancer Res
Dommer AP, Kumarasamy V, Wang J, O'Connor TN, Roti M, Mahan S, McLean K, Knudsen ES, Witkiewicz AK.   +8 more
europepmc   +1 more source

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma. [PDF]

Mol Cancer
Crawford KJ, Humphrey KS, Cortes E, Wang J, Kumarasamy V, Wan Y, Long MD, Feigin ME, Witkiewicz AK, Mann KM, Knudsen ES, Abel EV.   +11 more
europepmc   +1 more source

Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models. [PDF]

Mol Cancer Ther
Wu J, Wang J, O'Connor TN, Tzetzo SL, Gurova KV, Knudsen ES, Witkiewicz AK.   +6 more
europepmc   +1 more source

NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. [PDF]

J Immunol
Giridharan T, Suzuki S, Khan ANH, Liu Q, Attwood K, Stokolosa A, Mahan S, Witkiewicz AK, Joseph J, Moysich K, Langermann S, Lovewell R, Flies D, Myint H, Odunsi K, Emmons TR, Yaffe MB, Zsiros E, Dey P, McGray AJR, Segal BH.   +20 more
europepmc   +1 more source

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis. [PDF]

JCO Precis Oncol
Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, Bonnefoi H, Knudsen E, Im SA, DeMichele A, Van't Veer L, Kim SB, Bear H, McCarthy N, Rhiem K, Turner N, Witkiewicz A, Rojo F, Filipits M, Martin LA, Fasching PA, Schem C, Becker K, García-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Denkert C, Gnant M, Makris A, Liu Y, Valota O, Felder B, Weber K, Nekljudova V, Loibl S.   +37 more
europepmc   +1 more source

Perinatal Outcomes and Level of Labour Difficulty in Deliveries with Right and Left Foetal Position-A Preliminary Study. [PDF]

Healthcare (Basel)
Witkiewicz M, Baranowska B, Węgrzynowska M, Kiersnowska I, Karzel K, Bączek G, Sys D, Scholz A, Crowther S, Teliga-Czajkowska J, Tataj-Puzyna U.   +10 more
europepmc   +1 more source